Correlation Between Software Acquisition and Avadel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Software Acquisition and Avadel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Software Acquisition and Avadel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Software Acquisition Group and Avadel Pharmaceuticals PLC, you can compare the effects of market volatilities on Software Acquisition and Avadel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Software Acquisition with a short position of Avadel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Software Acquisition and Avadel Pharmaceuticals.

Diversification Opportunities for Software Acquisition and Avadel Pharmaceuticals

-0.15

Correlation Coefficient

Software Acquisition  Avadel Pharmaceuticals

Good diversification

The 3 months correlation between Software and Avadel is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Software Acquisition Group and Avadel Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avadel Pharmaceuticals and Software Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Software Acquisition Group are associated (or correlated) with Avadel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avadel Pharmaceuticals has no effect on the direction of Software Acquisition i.e., Software Acquisition and Avadel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Software Acquisition and Avadel Pharmaceuticals

Assuming the 90 days horizon Software Acquisition Group is expected to generate 7.41 times more return on investment than Avadel Pharmaceuticals. However, Software Acquisition is 7.41 times more volatile than Avadel Pharmaceuticals PLC. It trades about 0.13 of its potential returns per unit of risk. Avadel Pharmaceuticals PLC is currently generating about -0.03 per unit of risk. If you would invest  1.27  in Software Acquisition Group on December 21, 2024 and sell it today you would lose (0.25) from holding Software Acquisition Group or give up 19.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	77.97%
Values	Daily Returns

Software Acquisition Group  vs.  Avadel Pharmaceuticals PLC

Software Acquisition

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Software Acquisition Group are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak technical and fundamental indicators, Software Acquisition showed solid returns over the last few months and may actually be approaching a breakup point.

Avadel Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Software Acquisition and Avadel Pharmaceuticals

The main advantage of trading using opposite Software Acquisition and Avadel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Software Acquisition position performs unexpectedly, Avadel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avadel Pharmaceuticals will offset losses from the drop in Avadel Pharmaceuticals' long position.

The idea behind Software Acquisition Group and Avadel Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.